![]() |
市場調查報告書
商品編碼
1475207
全球注射包裝市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測Global Parenteral Packaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球注射劑包裝市場需求預計將從2023年的102.1億美元達到2032年近258.9億美元的市場規模,2024-2032年研究期間複合年成長率為10.89%。
腸胃外包裝是指用於無菌包裝注射藥物、液體和溶液的材料和容器,用於經由消化道以外的途徑給藥,例如靜脈注射、肌肉注射或皮下注射。這些包裝系統必須在藥品的整個保存期限內保持無菌、完整性和穩定性,保護其免受污染、光照和物理損壞。常見的胃腸外包裝材料包括玻璃瓶、安瓿、注射器和預填充藥筒,以及由聚丙烯、聚乙烯和環烯烴共聚物(COC)等材料製成的塑膠容器和袋子。
慢性病的日益普及、人口老化以及生物製藥的進步推動了對透過皮下 (SC) 注射和靜脈注射 (IV) 等注射途徑給藥的腸外藥物的需求。隨著醫療保健支出的增加、患者群體的擴大以及癌症、糖尿病、自體免疫疾病和傳染病注射療法的日益採用,對注射劑包裝解決方案的需求日益成長,以確保整個藥物過程中產品的完整性、相容性和病人安全生命週期。此外,包裝材料、容器封閉系統和無菌製造流程的進步使得注射包裝解決方案的開發成為可能,這些解決方案提供屏障保護、微生物穩定性和防篡改功能,以在儲存、運輸和運輸過程中保持藥物的效力、穩定性和無菌性。
此外,隨著製藥公司尋求能夠增強藥物依從性、促進自我給藥和改善患者治療效果的包裝解決方案,對以患者為中心的包裝、方便用戶使用的設計和合規性包裝的日益重視推動了市場創新。此外,注射劑包裝的監管要求、品質標準和行業指南(例如USP<797>、USP<800> 和ISO 13485)推動了市場合規性、品質保證和產品差異化,因為製造商努力滿足監管期望、減輕壓力。然而,嚴格的監管要求、安全標準和合規問題可能會阻礙未來幾年的市場成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球注射劑包裝市場的各個細分市場進行了包容性評估。注射劑包裝產業的成長和趨勢為本研究提供了整體方法。
注射包裝市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲腸外包裝市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。注射包裝市場的主要參與者包括 RPC Group、Unilife Corporation、Gerresheimer AG、Stevanato Group、Berry Plastics Corporation、Nipro Corporation、MeadWestvaco Corporation、Becton Dickinson and Company Inc.、Schott AG、Dickinson and Company Inc.、Ypsomed Holding AG 、Terumo Corporation、SiO2 Medical Products、West Pharmaceutical Services、Schott Pharmaceuticals Services Inc.、Owens-Illinois、Graphic Packaging Group。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Parenteral Packaging Market is presumed to reach the market size of nearly USD 25.89 Billion by 2032 from USD 10.21 Billion in 2023 with a CAGR of 10.89% under the study period 2024 - 2032.
Parenteral packaging refers to the materials and containers used for the sterile packaging injectable drugs, fluids, and solutions intended for administration via routes other than the digestive tract, such as intravenous, intramuscular, or subcutaneous injection. These packaging systems must maintain the sterility, integrity, and stability of the pharmaceutical product throughout its shelf life, protecting it from contamination, light exposure, and physical damage. Common parenteral packaging materials include glass vials, ampules, syringes, and pre-filled cartridges, as well as plastic containers and bags made from materials such as polypropylene, polyethylene, and cyclic olefin copolymer (COC).
The growing prevalence of chronic diseases, aging populations, and advancements in biopharmaceuticals drive the demand for parenteral medications administered via injection routes such as subcutaneous (SC) injections and intravenous (IV). With rising healthcare expenditures, expanding patient populations, and the increasing adoption of injectable therapies for cancer, diabetes, autoimmune diseases, and infectious diseases, there is a growing need for parenteral packaging solutions that ensure product integrity, compatibility, and patient safety throughout the drug lifecycle. Additionally, advancements in packaging materials, container closure systems, and sterile manufacturing processes enable the development of parenteral packaging solutions that offer barrier protection, microbial stability, and tamper-evident features to maintain drug potency, stability, and sterility during storage, transportation, and administration.
Moreover, the increasing emphasis on patient-centric packaging, user-friendly designs, and compliance packaging drives market innovation as pharmaceutical companies seek packaging solutions that enhance medication adherence, facilitate self-administration, and improve patient outcomes. Furthermore, regulatory requirements, quality standards, and industry guidelines for parenteral packagings, such as USP <797>, USP <800>, and ISO 13485, drive market compliance, quality assurance, and product differentiation as manufacturers strive to meet regulatory expectations, mitigate risks, and maintain product safety and efficacy. However, stringent regulatory requirements, safety standards, and compliance issues may hamper market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of parenteral packaging. The growth and trends of parenteral packaging industry provide a holistic approach to this study.
This section of the parenteral packaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Parenteral Packaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Packaging market include RPC Group, Unilife Corporation, Gerresheimer AG, Stevanato Group, Berry Plastics Corporation, Nipro Corporation, MeadWestvaco Corporation, Becton Dickinson and Company Inc., Schott AG, Dickinson and Company Inc., Ypsomed Holding AG, Terumo Corporation, SiO2 Medical Products, West Pharmaceutical Services, Schott Pharmaceuticals Services Inc., Owens-Illinois, Graphic Packaging Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.